Inventor · disambiguated record
Zhenwei Wu
Also filed as: WU ZHENWEI
6 granted patents·3 pending applications·49 citations·filing 2012–2023
78Inventor score
Files withDAI GUIFU2EVOPOINT BIOSCIENCES CO LTD2PURDUE RESEARCH FOUNDATION2SHENZHEN QIANHAI SHOUHUI SCIENCE AND TECH CULTURE CO LTD1UNIV IOWA STATE RES FOUND INC1
Top patents by PatentIndex Score
9 records- 0195US10967363B1Two-dimensional metal carbide catalystUNIV IOWA STATE RES FOUND INC·Filed 2018·Granted Apr 6, 2021·34 cites·22 claims
- 0288US11203010B2Catalyst for dehydrogenation of light alkanesPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Dec 21, 2021·4 cites·20 claims
- 0382USD992002SComputer cameraSHENZHEN QIANHAI SHOUHUI SCIENCE AND TECH CULTURE CO LTD·Filed 2021·Granted Jul 11, 2023·11 cites·1 claims
- 0472US12134084B2Catalyst for dehydrogenation of light alkanesPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Nov 5, 2024·0 cites·20 claims
- 0548US2025333541A1Antibody, and drug conjugate and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2023·Application pending·0 cites
- 0647US2024409628A1Antibody, antibody-drug conjugate thereof and use thereofEVOPOINT BIOSCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 0745US9636324B2Use of 15-benzylidence-14-deoxy-11, 12 -dehyroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virusUNIV ZHENGZHOU·Filed 2016·Granted May 2, 2017·0 cites·6 claims
- 0844US9388169B2Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virusDAI GUIFU·Filed 2013·Granted Jul 12, 2016·0 cites·5 claims
- 0927US2014187627A1Uses of c15-substituted andrographolide derivatives in the preparation of anti-hepatitis b virus medicamentDAI GUIFU·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhenwei Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →